Clinical Trials Browser

Phase 4 × Interventional × Lutetium-177 × Clear all

NCT05803941 2025-04-24

Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer

Phase 4 Recruiting

Prostatic Neoplasms

NCT01915485 2016-09-07

Radiolabeled Molecules for Medullary Thyroid Cancer

Phase 4 Unknown

Carcinoma, Medullary